Randomized Phase-III Study on HIPEC in Ovarian Cancer Impact on Patient Management

被引：0
|
作者：
Meier, W. [1 ]
机构：
[1] Univ Frauenklin Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany
来源：
ONKOLOGE | 2018年 / 24卷 / 09期
关键词：
PRIMARY SURGERY; CHEMOTHERAPY;
D O I：
10.1007/s00761-018-0424-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [31] SIZE OF PHASE-III CANCER CLINICAL-TRIALS
    SIMON, R
    CANCER TREATMENT REPORTS, 1985, 69 (10): : 1087 - 1093
  • [32] Health-related quality of life after hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer: Results of the phase III OVHIPEC study
    Koole, S.
    van Driel, W.
    Kieffer, J.
    Sikorska, K.
    van Leeuwen, J. Schagen
    Schreuder, H.
    Hermans, R.
    de Hingh, I.
    van der Velden, J.
    Arts, H.
    Massuger, L.
    Aalbers, A.
    Verwaal, V.
    Van de Vijver, K.
    Aaronson, N.
    Sonke, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] LOCATION OF RECURRENT DISEASE AFTER CYTOREDUCTION WITH OR WITHOUT HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR STAGE III OVARIAN CANCER: RESULTS OF THE PHASE III OVHIPEC STUDY
    Koole, S.
    Bruijs, L.
    Lahaye, M.
    Fabris, C.
    Sikorska, K.
    van Leeuwen, J. Schagen
    Schreuder, H.
    Hermans, R.
    de Hingh, I.
    van der Velden, J.
    Arts, H.
    Massuger, L.
    Aalbers, A.
    Verwaal, V.
    Van de Vijver, K.
    Sonke, G.
    van Driel, W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 611 - 612
  • [34] Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on "Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer-A Phase 3 Clinical Trial"
    Noiret, B.
    Bakrin, N.
    Eveno, C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 3357 - 3358
  • [35] Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
    Vergote, Ignace
    Harter, Philipp
    Chiva, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2420 - +
  • [36] ZOLADEX AND FLUTAMIDE VERSUS BILATERAL ORCHIECTOMY - A RANDOMIZED PHASE-III EORTC-30853 STUDY
    KEUPPENS, F
    DENIS, L
    SMITH, P
    CARVALHO, AP
    NEWLING, D
    BOND, A
    SYLVESTER, R
    DEPAUW, M
    VERMEYLEN, K
    ONGENA, P
    CANCER, 1990, 66 (05) : 1045 - 1057
  • [37] CISPLATIN-CYCLOPHOSPHAMIDE VERSUS CARBOPLATIN-CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CANCER - A RANDOMIZED PHASE-III STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
    SWENERTON, K
    JEFFREY, J
    STUART, G
    ROY, M
    KREPART, G
    CARMICHAEL, J
    DROUIN, P
    STANIMIR, R
    OCONNELL, G
    MACLEAN, G
    KIRK, ME
    CANETTA, R
    KOSKI, B
    SHELLEY, W
    ZEE, B
    PATER, J
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 718 - 726
  • [38] HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) A PROMISING TREATMENT FOR RELAPSED INTRAPERITONEAL OVARIAN CANCER. CHIPOR AN ONGOING PHASE III, EUROPEAN MULTICENTRIC RANDOMIZED TRIAL
    Classe, J. M.
    Campion, L.
    Meeus, P.
    Quenet, F.
    Leblanc, E.
    Werner, R.
    Ferron, G.
    Houvenaeghel, G.
    Gouy, S.
    Marchal, F.
    Barranger, E.
    Lecuru, F.
    Pocard, M.
    Guyon, F.
    Fontanier, S. Durand
    Glehen, O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1467 - 1468
  • [39] RANDOMIZED PHASE-III STUDY OF CHEMO-RADIOTHERAPY FOR SMALL CELL LUNG-CANCER (SCLC) STAGE LIMITED DISEASE
    ARNOLD, H
    KRAFT, A
    BODEMANN, H
    WANNENMACHER, M
    HINKELBEIN, W
    ZWINGERS, T
    VONBULTZINGSLOWEN, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 218 - 218
  • [40] RANDOMIZED PHASE-III STUDY OF CHEMO-RADIOTHERAPY FOR SMALL CELL LUNG-CANCER (SCLC) STAGE LIMITED DISEASE
    ARNOLD, H
    KRAFT, A
    BODEMANN, H
    WANNENMACHER, M
    HINKELBEIN, W
    ZWINGERS, T
    VONBULTZINGSLOWEN, F
    BLUT, 1988, 57 (04): : 251 - 251
12345